Zimmer’s new Patient Specific Reverse Shoulder system cleared by FDA

By

ZIMMER’S PATIENT SPECIFIC SHOULDER SYSTEM CLEARED FOR U.S  (Orthopedics This Week)
The FDA has given Zimmer Holdings, Inc. permission to market the company’s Patient Specific Instruments (PSI) Shoulder System for reverse shoulder arthroplasty procedures (RSA).
The system enables surgeons to plan the implant size and position, as well as bone preparation, including positioning the screw. It does this by utilizing 3D visualization software. European patients and surgeons have had access to the system since last May.
In an August 23, 2013 press release announcing the FDA clearance, Robert Munoz, ...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.